New data from the HDA Research Foundation show that sales through traditional pharmaceutical distributors grew 11.6% in 2025, reaching $969 billion. Published in the 97th Edition HDA Factbook, the findings provide a comprehensive look at the financial and operational performance of the pharmaceutical distribution sector.
“The latest Factbook demonstrates the scale and efficiency required to support the healthcare supply chain every day,” says Perry Fri, chief industry relations officer and president of the HDA Research Foundation. “Even as distributors operated on net profit margins of just 0.48 percent, they improved productivity, order fulfillment and expense management while continuing to invest in the systems and operations needed to serve customers and ensure patients can access the medicines they need.”



















